1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with dexchlorpheniramine in 3 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (dexchlorpheniramine) | Trials (dexchlorpheniramine) | Recent Studies (post-2010) (dexchlorpheniramine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 128 | 24 | 33 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | dexchlorpheniramine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 2.322 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 4.966 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 6.994 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 1.976 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 1.043 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 1.383 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 4.607 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 2.579 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 4.966 | |
| Histamine H2 receptor | Homo sapiens (human) | 8.368 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 3.692 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 2.322 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.025 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.0063 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.931 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 1.658 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Juhlin, L; Pihl-Lundin, I | 1 |
| Capron, A; Capron, M; De Vos, C; Joseph, M; Leprevost, C; Tomassini, M; Vorng, H | 1 |
| Capron, A; Capron, M; De Vos, C; Leprevost, C; Tomassini, M | 1 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and dexchlorpheniramine
| Article | Year |
|---|---|
Effects of antihistamines on cutaneous reactions and influx of eosinophils after local injection of PAF, kallikrein, compound 48/80 and histamine in patients with chronic urticaria and healthy subjects.
Topics: Adult; Aged; Chlorpheniramine; Chronic Disease; Eosinophils; Female; Histamine; Histamine H1 Antagonists; Humans; Kallikreins; Loratadine; Male; Middle Aged; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Skin; Urticaria | 1992 |
Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine.
Topics: Blood Platelets; Cetirizine; Chemotaxis, Leukocyte; Chlorpheniramine; Cytotoxicity, Immunologic; Eosinophils; Humans; Hydroxyzine; Hypersensitivity; Immunoglobulin E; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor | 1989 |
Inhibition of eosinophil chemotaxis by a new antiallergic compound (cetirizine).
Topics: Cell Survival; Cells, Cultured; Cetirizine; Chemotaxis, Leukocyte; Chlorpheniramine; Eosinophils; Exocytosis; Humans; Hydroxyzine; In Vitro Techniques; L-Lactate Dehydrogenase; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor | 1988 |